深圳國際(00152.HK)2020年純利達40.07億港元 末期息12.2港仙及特別息83.8港仙
格隆匯3月26日丨深圳國際(00152.HK)公佈2020年度業績,期內集團實現總收入194.52億港元,同比增長15.6%;毛利64.62億港元,同比下降3.5%;公司普通股權持有人應占純利40.07億港元,同比下降20.2%;每股基本盈利1.84港元,宣派末期股息每股0.122港元及特別股息每股0.838港元。
公吿稱,受集團持有49%權益的聯營公司深圳航空因疫情影響出現虧損,導致集團除税及財務成本前盈利及股東應占盈利分別較去年同期下跌2%及20%。若撇除深圳航空的因素,2020年度集團除税及財務成本前盈利及股東應占盈利均較去年上升17%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.